Theranostic Near-Infrared Monoamine Oxidase Inhibitor (NMI) Protein Binding Interactions with MAOA and Albumin
NMI was shown to interact with MAOA and the blood carrier protein, albumin. This study provides insights for drug delivery and protein target specificity of NMI to image and treat cancer.
Authors
- Unnati Hemant Shah
- Ronald W. Irwin
- Jean C. Shih (ORCID: https://orcid.org/0000-0003-2952-3246)
- Shivani Soni (ORCID: https://orcid.org/0009-0005-2189-7659)
- Heinz Josef Lenz
Institutions
- University of Southern California (US)
Publication Details
- Journal
- Pharmaceutical Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1007/s11095-025-03827-1
- Primary Topic
- Photoreceptor and optogenetics research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Southern California
- Dhont Family Foundation
- Division of Cancer Prevention, National Cancer Institute
- National Institutes of Health
- School of Pharmacy, University of Southern California
- National Cancer Institute